Cargando…
Rt-PA thrombolytic therapy in patients with acute posterior circulation stroke: A retrospective study
At present, recombinant tissue-type plasminogen activator (rt-PA) thrombolytic therapy is widely used in patients with acute ischemic stroke within 4.5 h following stroke onset. However, the efficacy of intravenous alteplase thrombolytic therapy for posterior circulation stroke (PCS) has been rarely...
Autores principales: | Hu, Yaozhi, Zheng, Haifei, Chen, Xiaohui, Gao, Zongen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829197/ https://www.ncbi.nlm.nih.gov/pubmed/36699100 http://dx.doi.org/10.3892/mi.2022.33 |
Ejemplares similares
-
Safety and Efficacy of Thrombolytic Therapy Using rt-PA (Alteplase) in Acute Ischemic Stroke
por: Sivanandy, Palanisamy, et al.
Publicado: (2011) -
Efficacy of Rosuvastatin Combined with rt-PA Intravenous Thrombolytic Therapy for Elderly Acute Ischemic Stroke Patients
por: Zhu, Jianzhong, et al.
Publicado: (2022) -
Retracted: Efficacy of Rosuvastatin Combined with rt-PA Intravenous Thrombolytic Therapy for Elderly Acute Ischemic Stroke Patients
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Thrombolytic treatment (alteplase; rt-Pa) in acute massive pulmonary embolism and cardiopulmonary arrest
por: Dirican, Adem, et al.
Publicado: (2014) -
Thrombolytic efficacy and enzymatic activity of rt-PA-loaded echogenic liposomes
por: Bader, Kenneth B., et al.
Publicado: (2015)